BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 116457)

  • 21. Metallo-β-lactamase-producing Pseudomonas aeruginosa in two Iranian teaching hospitals, their antimicrobial susceptibility and serotypes.
    Yousefi S; Nahaei MR; Farajnia S; Akhi MT; Ghotaslou R; Lotfipour F; Soroush MH
    J Chemother; 2011 Apr; 23(2):114-6. PubMed ID: 21571630
    [No Abstract]   [Full Text] [Related]  

  • 22. [Determination of the sensitivity of Pseudomonas aeruginosa to antibiotics using a synthetic liquid culture medium].
    Givental' NI; Bogdanova LF; Novak VL; Ved'mina EA; Sobolev VR
    Lab Delo; 1989; (6):56-9. PubMed ID: 2474709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Determination of Pseudomonas aeruginosa sensitivity to antibiotics and features of interpreting the results].
    Givental' NI
    Antibiot Med Biotekhnol; 1987 Sep; 32(9):674-83. PubMed ID: 3124726
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of antimicrobial agents on Pseudomonas aeruginosa strains isolated from sporadical cases and nosocomial infections.
    Meitert E; Sima F; Savulian C; Chersulick E; Petrescu AM
    Arch Roum Pathol Exp Microbiol; 1988; 47(3-4):227-38. PubMed ID: 3150919
    [No Abstract]   [Full Text] [Related]  

  • 25. P-nitrophenylglycerol in susceptibility media alters the MICs of antimicrobial agents for Pseudomonas aeruginosa.
    Bone FJ; Mundle R; Dale BA; MacRae KS; Wallace W
    J Antimicrob Chemother; 1994 Jan; 33(1):179-80; author reply 180-1. PubMed ID: 8157560
    [No Abstract]   [Full Text] [Related]  

  • 26. P-nitrophenylglycerol in susceptibility media alters the MICs of antimicrobial agents for Pseudomonas aeruginosa.
    Franklin JR; Hobson JA
    J Antimicrob Chemother; 1994 Jan; 33(1):179; author reply 180-1. PubMed ID: 8157559
    [No Abstract]   [Full Text] [Related]  

  • 27. Serotypes and antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa.
    Peng CF; Lin SR
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1987 May; 3(5):309-17. PubMed ID: 3133490
    [No Abstract]   [Full Text] [Related]  

  • 28. [Serotypes and antibiotic susceptibility of Pseudomonas aeruginosa isolated from clinical materials].
    Fujita K; Furuyama M; Kodama S; Murayama T; Takimoto M
    Kansenshogaku Zasshi; 1974 Feb; 48(2):57-62. PubMed ID: 4211643
    [No Abstract]   [Full Text] [Related]  

  • 29. The incidence of serotype O12 and multiresistance amongst Pseudomonas aeruginosa clinical isolates.
    Patzer J; Dzierzanowska D
    J Antimicrob Chemother; 1994 Jul; 34(1):165-70. PubMed ID: 7961204
    [No Abstract]   [Full Text] [Related]  

  • 30. Serological and pyocin typing and antibiotic sensitivity of Pseudomonas aeruginosa strains.
    Del Piano M; La Palombara P; Picci A; Nicosia R
    Microbiologica; 1986 Apr; 9(2):253-8. PubMed ID: 3086671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pseudomonas aeruginosa melanin].
    Rozhavin MA
    Antibiotiki; 1979 Jul; 24(7):511-4. PubMed ID: 223498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pseudomonas aeruginosa isolates with varying serotype and multiple antibiogram patterns from individual burn patients.
    Holder IA
    J Burn Care Rehabil; 1985; 6(6):482-6. PubMed ID: 3939638
    [No Abstract]   [Full Text] [Related]  

  • 33. [Fluorescent pseudomonads. Their antibiotic sensitivity, clinical significance and problems of identification].
    Shenderov BA
    Antibiot Med Biotekhnol; 1986 Mar; 31(3):225-34. PubMed ID: 3087273
    [No Abstract]   [Full Text] [Related]  

  • 34. Study of Pseudomonas aeruginosa-haemolysin by electrophoresis.
    Výmola F; Lochmann O; Buda J; Jedlicková Z; Pillich J
    J Hyg Epidemiol Microbiol Immunol; 1971; 15(1):23-7. PubMed ID: 4995066
    [No Abstract]   [Full Text] [Related]  

  • 35. [Serotype characteristics of clinical strains of Pseudomonas aeruginosa].
    Savitskaia KI; Levina EN; Akatova NS; Smirnova NS; Sinitsina GG
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Feb; (2):96-9. PubMed ID: 105521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pseudomonas aeruginosa strains: synergism and pyocinogenia induction].
    García-Quintana HG; Martińez MA
    Rev Med Chil; 1988 Nov; 116(11):1167-71. PubMed ID: 3151707
    [No Abstract]   [Full Text] [Related]  

  • 37. Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress.
    Ketelboeter LM; Bardy SL
    J Vis Exp; 2015 Aug; (102):e53105. PubMed ID: 26382879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivity of respiratory strains of Pseudomonas aeruginosa to carbenicillin.
    May JR; Ingold A
    J Med Microbiol; 1973 Feb; 6(1):77-82. PubMed ID: 4632255
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pseudomonas aeruginosa typing and its use for epidemiological analysis].
    Riapis LA; Dzhuzenov AA; Malikova NR; Vartanian ZhS; Ankirskaia AS; Kobel'kova IV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):110-1. PubMed ID: 8079527
    [No Abstract]   [Full Text] [Related]  

  • 40. Antimicrobial activity of fosfomycin against multidrug-resistant Pseudomonas aeruginosa in vitro.
    Kobayashi Y; Sumitani Y; Sugita K; Aikawa N
    Int J Antimicrob Agents; 2007 Dec; 30(6):563-4. PubMed ID: 17900870
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.